Aldhouse, Natalie V. J. http://orcid.org/0000-0001-6573-7431
Chan, Eric K. H.
Al-zubeidi, Tamara
McKee, Stephanie
Oriol Mathieu, Valérie
El khoury, Antoine C.
Kitchen, Helen
Funding for this research was provided by:
Janssen Pharmaceuticals
Article History
Accepted: 29 February 2024
First Online: 6 April 2024
Declarations
:
: This study was sponsored by Janssen. Clarivate received consulting fees for conducting this study and for preparation of the manuscript.
: Natalie V.J. Aldhouse, Tamara Al-zubeidi, Stephanie McKee, and Helen Kitchen are employees and stockholders of Clarivate, a health economic and outcomes research consultancy that consults with various pharmaceutical companies, including Janssen. Eric K.H. Chan and Antoine C. El khoury are employees of Janssen and stockholders of Johnson and Johnson. Valérie Oriol Mathieu is a current employee of Janssen Vaccines & Prevention B.V., which is part of the Johnson and Johnson companies, and may own stock or stock options in this company.
: The study protocol was reviewed and approved by the New England Institutional Review Board (NEIRB; 12 March 2020, study number: 1281308), and the study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.
: All study participants provided freely given, written, informed consent before taking part in the study. Verbal informed consent was also obtained prior to interviews.
: The datasets generated and/or analyzed during the current study are not publicly available due to confidentiality of the information. However, the corresponding author can be contacted for any data-related questions.
: NVJA, EKHC, VOM, ACE and HK conceptualized and designed this study, and approved the final protocol. NVJA, TAZ, and SM conducted the interviews and analyzed the data. All authors interpreted the data, and read and approved the final manuscript.